[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342255-105":59,"doc-detail-342255-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mechanistic-insights-into-sirt7-and-ezh2-regulation-of-cisplatin-resistance-in-bladder-cancer-cells","Mechanistic insights into SIRT7 and EZH2 regulation of cisplatin resistance in bladder cancer cells","","Cisplatin resistance significantly limits bladder cancer therapy, while SIRT7 and EZH2 are known regulators in bladder cancer biology. The study interrogates collaborative mechanisms driving cisplatin (CDDP) resistance using IHC and Western blot to measure SIRT7/EZH2 and RND3, cell viability and apoptosis-linked assays to test UMUC3 proliferation and drug sensitivity, and ChIP-qPCR/CO-IP/IP approaches to evaluate promoter epigenetic marks, protein binding, and EZH2 succinylation. In vivo validation is performed in a UMUC3 xenograft mouse model.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mechanistic-insights-into-sirt7-and-ezh2-regulation-of-cisplatin-resistance-in-bladder-cancer-cells/342255/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mechanistic-insights-into-sirt7-and-ezh2-regulation-of-cisplatin-resistance-in-bladder-cancer-cells/342255.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What relationship does SIRT7 show with cisplatin sensitivity in bladder cancer cells?","Question",{"text":112,"@type":113},"The findings report that SIRT7 correlates with both cisplatin sensitivity and platinum-based chemotherapy response in bladder cancer cells. SIRT7 binding to the RND3 promoter reduces H3K18ac and downregulates RND3, ultimately increasing cisplatin sensitivity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does EZH2 influence RND3 expression and cisplatin sensitivity?",{"text":117,"@type":113},"EZH2 siRNA decreases H3K27me3 levels at the RND3 promoter and increases RND3 expression. The study summarizes that promoter-region regulation by SIRT7 and EZH2 contributes to changes in RND3 and cisplatin sensitivity.",{"name":119,"@type":110,"acceptedAnswer":120},"Which experimental approaches are used to investigate the proposed regulatory mechanism?",{"text":121,"@type":113},"The study uses IHC and Western blot for expression profiling, CCK-8/plate clonogenic assays and flow cytometry for functional effects on proliferation and cisplatin response, and ChIP-qPCR with CO-IP/IP assays to assess promoter histone marks, SIRT7/EZH2 binding, and EZH2 succinylation. An in vivo xenograft mouse model is also employed for validation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342255,1790614612,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nMechanistic insights into SIRT7 and EZH2 regulation of cisplatin resistance in bladder cancer cells  \nYudong Cao1,3, Shuo Wang1,3, Jinchao Ma 1,3, Mengping Long2, Xiuli Ma2, Xiao Yang 1, Yongpeng Ji1, Xingxing Tang1, Jia Liu1, Chen Lin1, Yong Yang 1 and Peng Du 1 ✉  \n© The Author(s) 2024  \n\n| | Cisplatin (CDDP) resistance has been established to signiﬁcantly impact Bladder Cancer (BCa) therapy. On the other hand, the crucial regulatory involvement of SIRT7 and EZH2 in bladder cancer development is well known. Herein, the collaborative regulatory roles and underlying mechanisms of SIRT7 and EZH2 in CDDP resistance in bladder cancer were explored. Immunohistochemistry (IHC) and Western Blot (WB) analyses were used to assess the expression levels of SIRT7/EZH2 and RND3 in bladder cancer tissues, normal ureteral epithelial cells, and bladder cancer cell lines. Furthermore, the impact of various treatmentson of UMUC3 cell proliferation and CDDP sensitivity was assessed using CCK-8 assays, plate cloning assays, and ﬂow cytometry analysis. Additionally, the levels of H3K18ac and H3K27me3 at the promoter region of the RND3 gene, the binding abilities of SIRT7 and EZH2, and the succinylation level of the EZH2 protein were examined using ChIP-qPCR assays, CO-IP assays, and IP assays, respectively. Moreover, in vivo experiments were conducted using a bladder cancer mouse model created by subcutaneously injecting UMUC3 cells into Balb/c nude mice. According to the results, SIRT7 correlated with the sensitivity of bladder cancer cells to both the platinum-based chemotherapy and CDDP. Speciﬁcally, SIRT7 could bind to the RND3 promoter, downregulating H3K18ac and RND3, ultimately leading to an increased CDDP sensitivity in UMUC3 cells. Furthermore, EZH2 siRNA could decrease H3K27me3 levels in the RND3 promoter, upregulating RND3 . Overall, in the promoter region of the RND3 gene, SIRT7 upregulated H3K27me3 and EZH2 downregulated H3K18ac, leading to a decline in RND3 expression and CDDP sensitivity in bladder cancer cells. Additionally, SIRT7 reduced the succinylation of the EZH2 protein resulting in an EZH2-mediated RND3 downregulation. Therefore, targeting SIRT7 and EZH2 could be a viable approach to enhancing CDDP efﬁcacy in bladder cancer treatment. |  | |\n| --- | --- | --- | --- |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n|  |  |  |  |\n| |  |  | |\n|  | Cell Death and Disease (2024)15:931; [https://doi.org/10.1038/s41419-024-07321-1](https://doi.org/10.1038/s41419-024-07321-1) |  |  |\n|  |  |  |  |\n\nINTRODUCTION  \nBladder Cancer (BCa), the second most prevalent malignancy in the human urogenital system, has the highest mortality rate, attributable to its high recurrence rate and extensive resistance to anticancer medications [1] . Presently, platinum-based chemotherapy is the ﬁrst-line treatment for muscle-invasive and metastatic bladder cancer. Some of the platinum-based medications include Cisplatin (CDPP), carboplatin, and oxaliplatin. Notably, although 60–70% of CDPP-treated BCa patients exhibited a preliminary response to the drug, the Progression-Free Survival (PFS) and Overall Survival (OS) of most CDPP-treated BCa patients are often not satisfactory due to reduced responsiveness in the short term. This shortcoming remains a major challenge in BCa treatment of this disease [2] . Therefore, identifying the key targets that mediate CDDP sensitivity is crucial in BCa treatment, as well as in developing new therapeutic strategies for refractory bladder cancer [3] .  \nSirtuins (SIRTs), highly conserved enzymes known to target both histone and nonhistone proteins, are a family of NAD+-dependent deacetylases with seven members (SIRT1-SIRT7) [4] . Notably, mammalian SIRTs have been associated with multiple biological  \nprocesses, including ","cbCaigXxgOEaOt18","https://ap.wps.com/l/cbCaigXxgOEaOt18","pdf",10496821,"English","# Introduction\n# SIRT7 and EZH2 in cisplatin resistance\n# Methods for expression and mechanism analysis\n# Functional assays and in vivo validation\n# Key findings and therapeutic implications","[{\"question\":\"What relationship does SIRT7 show with cisplatin sensitivity in bladder cancer cells?\",\"answer\":\"The findings report that SIRT7 correlates with both cisplatin sensitivity and platinum-based chemotherapy response in bladder cancer cells. SIRT7 binding to the RND3 promoter reduces H3K18ac and downregulates RND3, ultimately increasing cisplatin sensitivity.\"},{\"question\":\"How does EZH2 influence RND3 expression and cisplatin sensitivity?\",\"answer\":\"EZH2 siRNA decreases H3K27me3 levels at the RND3 promoter and increases RND3 expression. The study summarizes that promoter-region regulation by SIRT7 and EZH2 contributes to changes in RND3 and cisplatin sensitivity.\"},{\"question\":\"Which experimental approaches are used to investigate the proposed regulatory mechanism?\",\"answer\":\"The study uses IHC and Western blot for expression profiling, CCK-8/plate clonogenic assays and flow cytometry for functional effects on proliferation and cisplatin response, and ChIP-qPCR with CO-IP/IP assays to assess promoter histone marks, SIRT7/EZH2 binding, and EZH2 succinylation. An in vivo xenograft mouse model is also employed for validation.\"}]","Mechanistic insights into SIRT7 and EZH2 regulation of cisplatin resistance in bladder cancer cells | PDF",1790045933,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c053122c89741ec8b432c98d3525a21.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d179a73018a2a9c21ca16dc470b4193c.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce48e5d556420c0431465311b6a04aef.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12631e54484f2535a085882c763d72f8.webp",980,1301]